Enphys Acquisition Stock Quote NFYS - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NYSE
Enphys Acquisition Corp (NFYS) Quote

Enphys Acquisition Corp (NFYS)

11.00

0.00

( 0.00% )

Updated: 20:00:00

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

11.00

Bid

-

Ask

-

Volume

-

0.00 Day's Range 0.00

10.40 52 Week Range 11.04

Market Cap

Previous Close

11.00

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

34,690

Shares Outstanding

13,070,291

Dividend Yield

-

PE Ratio

9.89

Earnings Per Share (EPS)

1.11

Revenue

-

Net Profit

14.53M

Enphys Acquisition Corp is a blank check company. Enphys Acquisition Corp is a blank check company.

Sector

Blank Checks

Industry

Blank Checks

Website

enphyspac.com

Headquarters

George Town, Cym

Founded

1970

Enphys Acquisition Corp is listed in the Blank Checks sector of the New York Stock Exchange with ticker NFYS. The last closing price for Enphys Acquisition was $11. Over the last year, Enphys Acquisition shares have traded in a share price range of $ 10.40 to $ 11.04.

Enphys Acquisition currently has 13,070,291 shares outstanding. The market capitalization of Enphys Acquisition is $143.77 million. Enphys Acquisition has a price to earnings ratio (PE ratio) of 9.89.

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.03	0.273473108478	10.97	11	10.97	1865	10.98131395	CS
4	0.04	0.36496350365	10.96	11	10.92	12007	10.96394463	CS
12	0.11	1.0101010101	10.89	11	10.84	34690	10.90562995	CS
26	0.28	2.61194029851	10.72	11.04	10.59	33784	10.83143349	CS
52	0.52	4.96183206107	10.48	11.04	10.4	86113	10.58813306	CS
156	1.43	14.9425287356	9.57	11.04	9.57	86533	10.17772734	CS
260	1.43	14.9425287356	9.57	11.04	9.57	86533	10.17772734	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
POAIPredictive Oncology Inc	$ 2.5094 (134.52%)	115.59M
PBMPsyence Biomedical Ltd	$ 0.73 (86.51%)	57.25M
SLRXSalarius Pharmaceuticals Inc	$ 3.275 (53.04%)	12.92M
VKTXViking Therapeutics Inc	$ 66.02 (30.97%)	7.23M
GSHDGoosehead Insurance Inc	$ 84.79 (29.06%)	322.28k
TWOU2U Inc	$ 1.59 (-61.41%)	2.05M
EZFLEzFill Holdings Inc	$ 3.86 (-37.99%)	50.01k
KDLYKindly MD Inc	$ 2.07 (-35.71%)	427.26k
MXLMaxLinear Inc	$ 16.0199 (-28.13%)	1.85M
GLYCGlycoMimetics Inc	$ 0.2279 (-26.55%)	3.86M
NVDANVIDIA Corporation	$ 110.5146 (-3.27%)	153.92M
POAIPredictive Oncology Inc	$ 2.5094 (134.52%)	115.59M
SLNASelina Hospitality PLC	$ 0.0432 (-5.47%)	110.58M
SQQQProShares UltraPro Short QQQ	$ 9.29 (2.54%)	78.76M
STSSSharps Technology Inc	$ 0.268 (12.94%)	57.48M

m$teamworkotc

m$teamworkotc 4 minutes ago

maybe the CEO can answer how mclains cancelled shares became freetrading? 203.5 million =1 million dollars for?
welcome to the PINK SEWERS

B_B!

B_B! 4 minutes ago

Nasdaq sells off for a second day as rotation out of tech continues, Russell 2000 rises: Live updates
UPDATED THU, JUL 25 2024
https://www.cnbc.com/2024/07/24/stock-market-today-live-updates.html

Investor2014

Investor2014 4 minutes ago

I just belong to those who like to get my information from almost anywhere but especially American TV ads.

BADALI

BADALI 4 minutes ago

https://x.com/thestockguru13/status/1804222900267876510?s=46&t=y7yrqIlNM3fsfWkjz_Q1IQ

Royal Dude

Royal Dude 4 minutes ago

CTM Intermediate Release 2 in Production
WHAT: DTCC's Institutional Trade Processing (ITP) has deployed a CTM ® Intermediate Release 2 into production.
WHEN: The release was successfully deployed on Saturday, July 20, 2024.
This release includes the following updates:
CTM

wadegarret

wadegarret 4 minutes ago

R59- GERN

Re, does if make you like GERN anymore, knowing that the only other competition(Reblozyl) is going at the pace of $1.2B/year treating low risk MDS ? Importantly, GERNs drug Rytelo effectively treats 4 times as many low risk MDS patients vs Bristol Myers Reblozyl. The reas

oldstocks

oldstocks 4 minutes ago

Just 2 years ago OneMind Technologies partnered with Corsight AI

Well Corsight AI is getting new contracts all over the world and the USA

July 27, 2022 / Affluence Corporation (OTC PINK:AFFU) a leader in Smart City Software and Internet of Things (IoT) technologies anno

Donotunderstand

Donotunderstand 4 minutes ago

yes

IMO that added dilution is priced in --- (although it will go down on the news)

if the ramp up of production and sales is fast enough ---- ??? -- that capital raise could well be the last until say 2027 when NKLA needs a SECOND factory to meet exploding demand and

Slojab

Slojab 4 minutes ago

Let's put this in perspective. Miller bought this supposed pile of calcium Oct 2 of last year. Without having the money to ship it or clients lined up to buy it. So, there it sits. Great business plan.

BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the Company has a

Nebuchadnezzar

Nebuchadnezzar 4 minutes ago

SHORT THIS SCAM INTO THE GROUND

LoserTrying2Win

LoserTrying2Win 4 minutes ago

Forget about here until September. They are off for the summer and hopefully will being pumping again then, starting with this merger with unknown texas company.

trunkmonk

trunkmonk 4 minutes ago

the key is, even if not coming up soon, sooner or later SEC WILL change hands, and the whole world of finance will change then, or before, depending on soooo many other countries already adopting cross border transfer coins.

Truth and Transparency

Truth and Transparency 4 minutes ago

Just the same canned responses that everyone has already posted. Meanwhile we are at a mere 17 cents pre reverse split

oilin07

oilin07 5 minutes ago

See ya guys over .01 soon!

newmedman

newmedman 5 minutes ago

Stable Genius....

https://x.com/brguest20/status/1816330745599910088

georgie18

georgie18 5 minutes ago

Yes Indeed it is...🥳

oniro3363

oniro3363 5 minutes ago

Was this discussed by COOP on earnings call this morning...?

JusticeWillWin

JusticeWillWin 5 minutes ago

Yes, the acquistion is a $1.4 billion "pure cash" transaction!
They explicitly said no equity will be involved and even better they continue buying back COOP shares, they increased the capacity by $200 million to $270 million!

Dilution of Equity is Off The Table! On the Contrar

jcromeenes

jcromeenes 5 minutes ago

Menace212

Menace212 5 minutes ago

oilin07

oilin07 5 minutes ago

Ground floor opportunity

sharkey1

sharkey1 5 minutes ago

Should make no differense, why should the FDA be involved with a legal desciscion , who cares if its Billy Bobs pill factory in Meana Ark. or phizer, , the obvious patent problem stays the same.
Purdue makes a new patent every year, and we all know why.

Mark

Mark 6 minutes ago

JFR161162

JFR161162 6 minutes ago

Yes the stock is oversold but don’t underestimate the hedge funds and their puppets (market makers) to continue their shenanigans.

My reading is they’re trying to make believe that MTD will be accepted.
Also, their actions (above average volume yesterday and today) suggest the

Enphys Acquisition

NLBNPIT1V6D7 20351221 0....

Delayed Upgrade Clock